Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Canadian Solar (NASDAQ:CSIQ), Elme (NYSE:ELME)

Benzinga
Abrir em Benzinga
Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Canadian Solar (NASDAQ:CSIQ), Elme (NYSE:ELME)

U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Thursday.

Shares of Immuneering Corp (NASDAQ: IMRX ) fell sharply in pre-market trading .

The company announced updated overall survival and safety data from its ongoing Phase 2a trial of atebimetinib in combination with modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer patients, with over 13 months median follow up time.

Immuneering shares dipped 20.7% to $6.61 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

Elme Communities (NYSE: ELME ) shares dipped 82.8% to $2.98 in pre-market trading. Erasca Inc (NASDAQ: ERAS ) fell 14% to $4.45 in pre-market trading after rising 42% on Wednesday. Phathom Pharmaceuticals Inc (NASDAQ: PHAT ) fell 13.7% to $15.60 in pre-market trading.  Phathom Pharmaceuticals announced pricing of $130 million public offering of common stock and pre-funded warrants. United Microelectronics Corp (NYSE: UMC ) fell 6.3% to $8.37 in pre-market trading. United Microelectronics shares jumped 10% on Wednesday after the company reported December and full-year sales growth. Canadian Solar Inc (NASDAQ: CSIQ ) declined 6.1% to $20.68 in pre-market trading after the company announced a $200 million proposed public offering. Trevi Therapeutics Inc (NASDAQ: TRVI ) fell 6.1% to $11.00 in pre-market trading. Revolution Medicines Inc (NASDAQ: RVMD ) dipped 6% to $96.57 in pre-market trading following reports suggesting AbbVie is not in discussions with the company. Sibanye Stillwater Ltd (NYSE: SBSW ) fell 5.7% to $15.01 in pre-market trading. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ) fell 5% to $8.11 in pre-market trading. In December, the U.S. Food and Drug Administration (FDA) approved Vanda Pharmaceuticals' Nereus (tradipitant) to prevent vomiting induced by motion. Logitech International SA (NASDAQ: LOGI ) declined 4.8% to $94.91 in pre-market trading. Logitech International announced that it expects to release third quarter fiscal year 2026 financial results on Tuesday, Jan. 27. United Microelectronics Corp (NYSE: UMC ) fell 4% to $8.57 in pre-market trading. United Microelectronics shares jumped 10% on Wednesday after the company reported December and full-year sales growth.

Now Read This:

Top 2 Materials Stocks That May Implode In January

Photo via Shutterstock

CSIQ Canadian Solar Inc $20.80 -5.54% Overview ELME Elme Communities $2.80 5.26% ERAS Erasca Inc $4.55 -12.0% IMRX Immuneering Corp $6.40 -23.2% LOGI Logitech International SA $93.84 -5.88% PHAT Phathom Pharmaceuticals Inc $16.00 -11.5% RVMD Revolution Medicines Inc $95.00 -7.51% SBSW Sibanye Stillwater Ltd $14.81 -6.97% TRVI Trevi Therapeutics Inc $11.72 0.09% UMC United Microelectronics Corp $8.53 -4.48% VNDA Vanda Pharmaceuticals Inc $7.36 -13.8% Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Add Comment | 1
Posted In: News Pre-Market Outlook Markets Movers Trading Ideas big losers